Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

155.17 -0.33 (-0.21%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
99 100 Next >
Nearing Retirement? These Stocks Are as Safe as They Come
These stocks should provide solid income with little drama. 
Via The Motley Fool
Walgreens Boots Alliance Just Cut Its Dividend: Here Are 2 Companies That Won't
Not every dividend stock is created equal, and these two far exceed Walgreens Boots Alliance. 
Via The Motley Fool
My 5 Top Dividend Stocks to Buy Hand Over Fist in 2024
These stocks may help you win in 2024 -- no matter what the market does. 
Via The Motley Fool
3 High-Flying Stocks That Could Soar Even More in 2024
These big winners could keep the momentum going. 
Via The Motley Fool
Q4 Earnings Results Reflect Stability
We get into the heart of the Q4 earnings season this week, with more than 225 companies reporting results, including 71 S&P 500 members from various sectors and industries 
Via Talk Markets
Topics Stocks
Exposures US Equities
How Is The Market Feeling About Johnson & Johnson?
Via Benzinga
3 Dividend Stocks For A Steady Drip Of Income
Dividend Reinvestment Plans allow investors to unleash the power of compounding dividends. 
Via Talk Markets
Johnson & Johnson Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
A Closer Look at Johnson & Johnson's Options Market Dynamics
Via Benzinga
3 Reasons to Rely on Dividend Stocks
Dividend stocks can be a great hedge against volatile while still providing powerful returns via compounding. 
Via InvestorPlace
7 Must-Have Stocks for Serious Wealth Accumulation
Unlock the strategies of seven finance and commerce stalwarts on the path to serious wealth accumulation and industry leadership. 
Via InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)
From Brodsky & Smith LLC
Via GlobeNewswire
The 3 Most Undervalued Value Stocks to Buy in January
With so many investments turning in a surprisingly robust performance last year, it’s time to consider undervalued value stocks. 
Via InvestorPlace
Is Johnson & Johnson Stock a Buy Now?
The pharmaceutical giant recently announced another acquisition. 
Via The Motley Fool
Balancing Dividends and Fundamentals: The Case of NYSE:JNJ.
Why JOHNSON & JOHNSON (NYSE:JNJ) provides a good dividend, while having solid fundamentals. 
Via Chartmill
4 Fantastic Dividend King Stocks to Buy in 2024
All four of these companies have been increasing their dividend payouts for over 50 years. 
Via The Motley Fool
Hidden High-Yielders: 7 Overlooked Stocks with Attractive Dividends
Here are seven overlooked high-yield dividend stocks for you to consider no matter where interest rates at the end of 2024. 
Via InvestorPlace
2 Former Warren Buffett Stocks That Stand Out as Stong Buys in 2024
Berkshire Hathaway exited its positions in these two blue chip dividend stocks last year, but they are still superb buys for certain types of investors. 
Via The Motley Fool
Week In Review: China Biopharmas Book $9 Billion In Deals During JP Morgan Conference Week
Shanghai Argo Biopharma entered 2 agreements with Novartis, out-licensing four next-gen RNAi therapeutics for $185 million upfront and a total value of $4.2 billion. Additionally, Ambrx Biopharma will... 
Via Talk Markets
2 Average Stocks That Could Make You Rich
You don't always have to pick a game-changing company to win in the stock market. 
Via The Motley Fool
Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review
The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut. 
Via Investor's Business Daily
Topics ETFs
Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology Space
The companies are working on blocking TL1A, a protein tied to inflammatory bowel disease. 
Via Investor's Business Daily
Dividend Dynasty: 7 High-Yield Stocks for Long-Term Wealth Accumulation
Navigate 'Dividend Dynasty': Uncover seven high-yield stocks combining stable dividends with sustainable growth strategies. 
Via InvestorPlace
Walgreens Cut Its Dividend by 48%: Here Are 5 Better Dow Dividend Stocks to Buy in January
Businesses with efficient operations and growth potential open the door to dividend raises for years to come. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Why Eli Lilly Stock Skyrocketed 59% in 2023
Lilly's pipeline success in 2023 allowed it to to claim the crown as the biggest drugmaker on the planet by market cap. 
Via The Motley Fool
2 Dow Stocks to Buy Hand Over Fist in 2024 and 1 to Avoid Like the Plague
Among the Dow Jones Industrial Average's 30 time-tested components, there are two that are historically cheap and ripe for the picking, while another outperformer is riddled with issues. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
3 Unshakeable Dividend Stocks for Lifelong Wealth
No matter what the circumstances, passive income won’t go out of style, thus driving the case for these long-term dividend stocks. 
Via InvestorPlace
7 Stable Stocks to Buy No Matter What Happens to Interest Rates
With investors still facing uncertainty in 2024, they may find greater comfort by targeting certain stable stocks to buy. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Illumina Shares Trading Higher After Confirming Partnership With Johnson & Johnson Unit
Illumina, Inc. (NASDAQ: ILMN) shares are trading higher after announcing preliminary financial results for the fourth quarter (Q4) and  
Via Benzinga
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.